Urokinase-type plasminogen activator (uPA) and its inhibitor, plasminogen activator inhibitor type 1 (PAI-1), play essential roles in tumor invasion and metastasis, being involved in degradation of the tumor stroma and basement membrane [1]. Here, PLAU is linked to neoplasm.